HCM

MKT CAP:$2B

HUTCHMED DRC

Market Cap

$2B

Healthcare·Drug Manufacturers - Specialty & Generic·🇺🇸 United States·NASDAQ

Healthcare·Drug·🇺🇸·NASDAQ

Stock Price

$10.85-$2.80 (-20.51%)

Jun 8, 2026

52W High $19.2152W Low $10.85

Company Details

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally. It ...

CEO

—

IPO Date

Mar 17, 2016

Website

www.hutch-med.com

Key Metrics TTM

Revenue

$602M

-1.4% YoY

Net Income

$467M

EPS (Diluted)

Free Cash Flow

-$50M

Revenue / Share

$3.45

Gross Margin

8.9%

Operating Margin

-3.3%

Net Margin

77.5%

FCF Margin

-8.2%

P/S

3.3x

P/E

4.2x

Earnings Reports

Q2 2026

Jul 30, 2026

PENDING

FY 2025

Mar 5, 2026

$550M-12.7%

Q2 2025

Aug 7, 2025

$139M-9.2%

Q1 2025

May 28, 2025

$139M-9.2%

FY 2024

Mar 19, 2025

$630M-24.8%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding